CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of CNBX Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CNBX Pharmaceuticals Inc market cap is $37,000.00.
What is the 52-week high for CNBX Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CNBX Pharmaceuticals Inc 52 week high is $0.0199 as of September 07, 2025.
What is the 52-week low for CNBX Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CNBX Pharmaceuticals Inc 52 week low is $0.0003 as of September 07, 2025.
What is CNBX Pharmaceuticals Inc stock price today?
CNBX Pharmaceuticals Inc stock price today is $0.0004.
What was CNBX Pharmaceuticals Inc stock price yesterday?
CNBX Pharmaceuticals Inc stock price yesterday was $0.0004.
What is the PE ratio of CNBX Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CNBX Pharmaceuticals Inc’s P/E ratio is -0.06.
What is the Price-to-Book ratio of CNBX Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CNBX Pharmaceuticals Inc P/B ratio is -0.0146.
What is the 50-day moving average of CNBX Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CNBX Pharmaceuticals Inc 50-day moving average is $0.0006.
How many employess does CNBX Pharmaceuticals Inc has?